Quasi Experimental Study to Ascertain Link of PPI to Bone Profile in Healthy Individuals
Link of PPI to Bone Profile
DOI:
https://doi.org/10.54393/pjhs.v4i09.1039Keywords:
Vitamin D, Calcium, PPIAbstract
Proton pump inhibitor (PPI) is only acid blocking agent used for treating the disease known as gastroesophageal reflux (non-erosive), erosive esophagitis disease, dyspepsia disease and the peptic ulcer disease because of its efficacy and potency. However, overuse of it is examined an immediate result of absence of determination of need for steady treatment in many outdoor subjects Objective: To evaluate impact of proton pump inhibitor (PPI) on bone biochemistry in young individuals of Hyderabad. Methods: The study contained 227 young individuals of age 20-45 years, it was conducted in Liaquat University Hospital, Hyderabad City and Medicine OPD’s of Jamshoro. The research study is undertaken using Quasi experimental study. The study duration is 6 months starting from 15th March 2020 to 15th September 2020 and sampling technique is non – probability convenience. SPSS 21 software is used to analyze the data. The post stratification chi – square test is performed at the interval of 95% confidence, besides it the P-value is observed ≤ 0.05. Results: There is no effect on serum calcium and vitamin D levels with use of proton pump inhibitor PPI. P-value was observed 0.7 for the serum calcium and the p- value for Serum Vitamin D was 0.1. Conclusions: Hence, the study showed that proton pump inhibitor PPI use for less than 6 months have no effect on bone biochemistry.
References
Naqvi S, Saqib S, Khan W, Syed I. Rising use of Proton Pump inhibitors: A Karachi perspective. Science International (Lahore). 2014 Nov; 26(5): 1941-4.
Khalili H, Huang ES, Jacobson BC, Camargo CA, Feskanich D, Chan AT. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ. 2012 Jan; 344: e372. doi: 10.1136/bmj.e372. DOI: https://doi.org/10.1136/bmj.e372
Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006 Dec; 296(24): 2947-53. doi: 10.1001/jama.296.24.2947. DOI: https://doi.org/10.1001/jama.296.24.2947
Kaye JA and Jick H. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2008 Aug; 28(8): 951-9. doi: 10.1592/phco.28.8.951. DOI: https://doi.org/10.1592/phco.28.8.951
Jacobson BC, Ferris TG, Shea TL, Mahlis EM, Lee TH, Wang TC. Who is using chronic acid suppression therapy and why? The American Journal of Gastroenterology. 2003 Jan; 98(1): 51-8. doi: 10.1111/j.1572-0241.2003.07186.x. DOI: https://doi.org/10.1111/j.1572-0241.2003.07186.x
Tuukkanen J and Väänänen HK. Omeprazole, a specific inhibitor of H+− K+-ATPase, inhibits bone resorption in vitro. Calcified Tissue International. 1986 Mar; 38(2): 123-5. doi: 10.1007/BF02556841. DOI: https://doi.org/10.1007/BF02556841
Elaine WY, Bauer SR, Bain PA, Bauer DC. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. The American Journal of Medicine. 2011 Jun; 124(6): 519-26. doi: 10.1016/j.amjmed.2011.01.007. DOI: https://doi.org/10.1016/j.amjmed.2011.01.007
Fraser LA, Leslie WD, Targownik LE, Papaioannou A, Adachi JD, CaMos Research Group. The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporosis International. 2013 Apr; 24: 1161-8. doi: 10.1007/s00198-012-2112-9. DOI: https://doi.org/10.1007/s00198-012-2112-9
Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Ziegler TE, Penniston KL, et al. Do proton pump inhibitors decrease calcium absorption? Journal of Bone and Mineral Research. 2010 Dec; 25(12): 2786-95. doi: 10.1002/jbmr.166.
Wright MJ, Proctor DD, Insogna KL, Kerstetter JE. Proton pump-inhibiting drugs, calcium homeostasis, and bone health. Nutrition Reviews. 2008 Feb; 66(2): 103-8. doi: 10.1111/j.1753-4887.2008.00015.x. DOI: https://doi.org/10.1111/j.1753-4887.2008.00015.x
Need AG, O'Loughlin PD, Morris HA, Coates PS, Horowitz M, Nordin BC. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. Journal of Bone and Mineral Research. 2008 Nov; 23(11): 1859-63. doi: 10.1359/jbmr.080607. DOI: https://doi.org/10.1359/jbmr.080607
Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Official journal of the American College of Gastroenterology| ACG. 2011 Jul; 106(7): 1209-18. doi: 10.1038/ajg.2011.113. DOI: https://doi.org/10.1038/ajg.2011.113
Laine, Ahnen, Mcclain, Solcia, Walsh. Potential gastrointestinal effects of long‐term acid suppression with proton pump inhibitors. Alimentary Pharmacology & Therapeutics. 2000 Jun; 14(6): 651-68. doi: 10.1046/j.1365-2036.2000.00768.x. DOI: https://doi.org/10.1046/j.1365-2036.2000.00768.x
Sachs G, Shin JM, Howden CW. The clinical pharmacology of proton pump inhibitors. Alimentary Pharmacology & Therapeutics. 2006 Jun; 23: 2-8. doi: 10.1111/j.1365-2036.2006.02943.x. DOI: https://doi.org/10.1111/j.1365-2036.2006.02943.x
Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. Journal of Neurogastroenterology and Motility. 2011 Jan; 17(1): 14. doi: 10.5056/jnm.2011.17.1.14. DOI: https://doi.org/10.5056/jnm.2011.17.1.14
Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Official journal of the American College of Gastroenterology| ACG. 2007 Sep; 102(9): 2047-56. doi: 10.1111/j.1572-0241.2007.01275.x. DOI: https://doi.org/10.1111/j.1572-0241.2007.01275.x
Jackson MA, Goodrich JK, Maxan ME, Freedberg DE, Abrams JA, Poole AC, Sutter JL, Welter D, Ley RE, Bell JT, Spector TD. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016 May; 65(5): 749-56. doi: 10.1136/gutjnl-2015-310861. DOI: https://doi.org/10.1136/gutjnl-2015-310861
Mizunashi K, Furukawa Y, Katano K, Abe K. Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans. Calcified Tissue International. 1993 Jul; 53: 21-5. doi: 10.1007/BF01352010. DOI: https://doi.org/10.1007/BF01352010
Hardy P, Sechet A, Hottelart C, Oprisiu R, Abighanem O, Said S, et al. Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. Artificial Organs. 1998 Jul; 22(7): 569-73. doi: 10.1046/j.1525-1594.1998.06200.x. DOI: https://doi.org/10.1046/j.1525-1594.1998.06200.x
Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Ziegler TE, Penniston KL, et al. Do proton pump inhibitors decrease calcium absorption? Journal of Bone and Mineral Research. 2010 Dec; 25(12): 2786-95. doi: 10.1002/jbmr.166. DOI: https://doi.org/10.1002/jbmr.166
Kocsis I, Arató A, Bodánszky H, Szonyi L, Szabó A, Tulassay T, et al. Short-term omeprazole treatment does not influence biochemical parameters of bone turnover in children. Calcified Tissue International. 2002 Aug; 71(2): 129-32. doi: 10.1007/s00223-001-2068-9. DOI: https://doi.org/10.1007/s00223-001-2068-9
Moayyedi P and Cranney A. Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm. Official Journal of the American College of Gastroenterology| ACG. 2008 Oct; 103(10): 2428-31. doi: 10.1111/j.1572-0241.2008.02031.x. DOI: https://doi.org/10.1111/j.1572-0241.2008.02031.x
Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. Canadian Medical Association Journal. 2008 Aug; 179(4): 319-26. doi: 10.1503/cmaj.071330. DOI: https://doi.org/10.1503/cmaj.071330
Wright MJ, Sullivan RR, Gaffney‐Stomberg E, Caseria DM, O'Brien KO, Proctor DD, et al. Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial. Journal of Bone and Mineral Research. 2010 Oct; 25(10): 2205-11. doi: 10.1002/jbmr.108. DOI: https://doi.org/10.1002/jbmr.108
Sharara AI, El-Halabi MM, Ghaith OA, Habib RH, Mansour NM, Malli A, et al. Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study. Metabolism. 2013 Apr; 62(4): 518-26. doi: 10.1016/j.metabol.2012.09.011. DOI: https://doi.org/10.1016/j.metabol.2012.09.011
Moayyedi P. Hip fracture and proton pump inhibitor therapy: position statement. Canadian Journal of Gastroenterology and Hepatology. 2008 Oct; 22: 855-6. doi: 10.1155/2008/284165. DOI: https://doi.org/10.1155/2008/284165
Serfaty-Lacrosniere C, Wood RJ, Voytko D, Saltzman JR, Pedrosa M, Sepe TE, et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. Journal of the American College of Nutrition. 1995 Aug; 14(4): 364-8. doi: 10.1080/07315724.1995.10718522. DOI: https://doi.org/10.1080/07315724.1995.10718522
Graziani G, Como G, Badalamenti S, Finazzi S, Malesci A, Gallieni M, et al. Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects. Nephrology Dialysis Transplantation. 1995 Jan; 10(8): 1376-80.
Del Valle HB, Yaktine AL, Taylor CL, Ross AC, editors. Dietary reference intakes for calcium and vitamin D. The National Academies Press ; 2011.
O’Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. The American journal of medicine. 2005 Jul; 118(7): 778-81. doi: 10.1016/j.amjmed.2005.02.007. DOI: https://doi.org/10.1016/j.amjmed.2005.02.007
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pakistan Journal of Health Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments
